StratDeckLLY

Eli Lilly and Company

LLY✓
Share

Healthcare · Drug Manufacturers - General · United States

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Price1138.28USD
1D+2.02%
Market cap1.02T
AnalystsBuy29
Next earnings29 Oct
Loading chart…

Trade ideas

  • Opinionated - ValueGood Opportunities—Paying up for qualityBuy29Board

Analysts

ConsensusBuy29
Mean score1.70
Mean target1318.66+15.85%
Target range930.00–1600.00

Value vs sector peers

#26 of 26 in HealthcarePaying up for quality7
  • Fwd P/E24.18
  • P/B30.00
  • Yield0.6%9
  • P/E38.213
  • Rev growth+47.7%100

Nearest in Healthcare

  1. #23TMOThermo Fisher Scientific Inc.Paying up for quality23
  2. #24VRTXVertex Pharmaceuticals IncorporatedPaying up for quality20
  3. #25ISRGIntuitive Surgical, Inc.Paying up for quality10
  4. #26LLYEli Lilly and CompanyPaying up for quality7

Fundamentals

P/E38.2
Forward P/E24.1
Price / book29.95
Dividend yield0.62%
Beta0.50
52-week range712.05–1292.6573/100
ADV (USD)2.92B
Relative volume0.9
10d avg volume2.32M
Revenue growth+47.70%
EPS growth+26.20%

Performance

1D+2.02%
7D-0.96%
1M-3.55%
3M+0.94%
6M+15.44%
YTD+6.43%

In the briefing and the feed

Briefing for 11 Sept

Neither the briefing nor the research feed has named LLY.

Catalysts

Next earnings: 29 Oct

Trade idea history

No trade idea has fired on LLY since the ledger opened.

Get it by email

The board LLY sits on, in one five-minute email every weekday before the New York open and on Saturdays: market strength, the biggest movers, earnings coming up and the names sitting at their 200-day EMA.